H. Mamon

发表

Clinical feasibility of using an EPID in CINE mode for image-guided verification of stereotactic body radiotherapy.

Ross I Berbeco, Dan Ionascu, Fred Hacker, 2007, International journal of radiation oncology, biology, physics.

A novel method for estimating SBRT delivered dose with beam's-eye-view images.

Ross I Berbeco, Sang-June Park, Dan Ionascu, 2008, Medical Physics (Lancaster).

A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.

Emily M. Thrash, R. Mak, R. Tishler, 2020, International journal of radiation oncology, biology, physics.

Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients

Hugo J. W. L. Aerts, Harvey Mamon, T. Coroller, 2016, Front. Oncol..

Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction

Stephen S F Yip, Ross I Berbeco, Hugo J W L Aerts, 2016, Physics in medicine and biology.

Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients

T. Coroller, H. Aerts, R. Berbeco, 2016, Front. Oncol..

Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line.

T. Roberts, B. Druker, J. Griffin, 1991, Blood.

Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.

Jeffrey W. Clark, C. Willett, D. Ryan, 2011, International journal of radiation oncology, biology, physics.

Allergic Skin Reactions to Anticonvulsant Medications in Patients Receiving Cranial Radiation Therapy

P. Wen, J. Loeffler, H. Mamon, 1999, Epilepsia.

Short-course versus standard chemoradiation in T3 rectal cancer.

T. Hong, H. Mamon, 2011, The oncologist.

Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer.

M. Blake, A. Zhu, T. Hong, 2017, Practical radiation oncology.

The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation

D. Ryan, E. Kwak, T. Hong, 2016, American journal of clinical oncology.

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

J. Meyerhardt, R. Bueno, N. Choi, 2016, BMC Cancer.

Perioperative radiotherapy for cancer of the esophagus.

F. Wenz, H. Mamon, 2001, Seminars in surgical oncology.

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer.

A. Zhu, D. Ryan, E. Kwak, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma

B. Yeap, T. Hong, H. Mamon, 2009, Cancer.

Supportive and palliative radiation oncology service: impact of a dedicated service on palliative cancer care.

M. Pacold, H. Mamon, J. Abrahm, 2014, Practical radiation oncology.

Rectal and Colon Cancer: Radiation Therapy Planning

H. Mamon, S. Kamran, J. Wo, 2017 .

Long-term follow-up of a paradigm-changing study: the paradigm still holds.

H. Mamon, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early-Stage Rectal Cancer: Clinical and Pathologic Prognostic Markers of Time to Local Recurrence and Overall Survival After Resection

T. Hong, J. Hornick, H. Mamon, 2014, Diseases of the colon and rectum.

Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study.

R. Mak, K. Hoffman, E. McCarthy, 2011, International journal of radiation oncology, biology, physics.

Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

Jeffrey W. Clark, A. Zhu, D. Ryan, 2014, Journal of Gastrointestinal Cancer.

Patient‐reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer

Ronald C. Chen, Jeffrey W. Clark, R. Gelman, 2010, Cancer.

Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.

S. Haneuse, M. Rinard, I. Kaplan, 2020, European journal of cancer.

Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

T. Kim, K. Goodman, L. Dawson, 2014, Practical radiation oncology.

The Survival Benefit From the Addition of Radiation to Chemotherapy in Gastric Cancer Patients Following Surgical Resection.

X. Wang, H. Mamon, Y. Sun, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype

Jeffrey W. Clark, B. Yeap, A. Zhu, 2017, Journal of the National Cancer Institute.

Dosimetric predictors of nausea and vomiting: an exploratory analysis of a prospective phase I/II trial with neoadjuvant accelerated short-course radiotherapy and capecitabine for resectable pancreatic cancer

T. Hong, H. Mamon, Judy A. Adams, 2013, Journal of Radiation Oncology.

Perils of the Pathologic Complete Response.

E. Winer, H. Mamon, B. Rose, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.

C. Willett, D. Ryan, D. T. Miyamoto, 2008, International journal of radiation oncology, biology, physics.

Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center.

S. Weingart, L. Shulman, H. Mamon, 2010, Journal of oncology practice.

KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

M. Shah, P. Enzinger, Xiaolong Fu, 2021, Future oncology.

Combination chemoradiation therapy: the whole is more than the sum of the parts.

J. Tepper, H. Mamon, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infrared-guided patient setup for lung cancer patients.

L. Chin, H. Mamon, J. Killoran, 2008, International journal of radiation oncology, biology, physics.

Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples.

E. Maher, Fengfei Wang, H. Mamon, 2006, Clinical chemistry.

Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.

D. Rattner, J. Meyerhardt, R. Bueno, 2013, The oncologist.

Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.

M. Ferrari, H. Mamon, L. Cremonesi, 2012, Clinical chemistry.

Temperature-Tolerant COLD-PCR Eliminates Temperature Stringency and Enables Robust Mutation Enrichment

M. Ferrari, H. Mamon, L. Cremonesi, 2012 .

Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.

A. Zhu, D. Ryan, E. Kwak, 2014, Practical radiation oncology.

Interstitial Lung Abnormalities in Patients With Locally Advanced Esophageal Cancer: Prevalence, Risk Factors, and Clinical Implications

H. Hatabu, M. Nishino, H. Mamon, 2022, Journal of computer assisted tomography.

A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.

Emily M. Thrash, R. Mak, R. Tishler, 2019, International journal of radiation oncology, biology, physics.

Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells

T. Roberts, H. Mamon, K. Smith, 1991, Molecular and cellular biology.

Reply to S. Sorscher.

E. Winer, H. Mamon, B. Rose, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101.

C. Willett, C. Fuchs, J. Tepper, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.

K. Lillemoe, D. Ryan, E. Kwak, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer.

T. Hong, J. Wolfgang, H. Mamon, 2013, Practical radiation oncology.

TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.

Jeffrey W. Clark, K. Lillemoe, Y. Boucher, 2017 .

Reply to E. C. Smyth et al.

J. Tepper, H. Mamon, 2014, Journal of Clinical Oncology.

The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.

R. Bueno, B. Yeap, P. Enzinger, 2015, Seminars in thoracic and cardiovascular surgery.

Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

H. Mamon, M. Kulke, Wei‐hua Liu, 2006, The Journal of molecular diagnostics : JMD.

Esophageal cancer with signet-ring cell features is associated with poor prognosis in the modern treatment era: factors influencing overall and disease-free survival

R. Bueno, S. Swanson, Deepa T. Patil, 2020 .

Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.

J. Meyerhardt, P. Enzinger, D. Schrag, 2014, The oncologist.

Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer

H. Mamon, Hollis Luk, L. Wong, 2022, Clinical and translational radiation oncology.

Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.

P. Enzinger, H. Mamon, M. Jaklitsch, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma.

A. Shinagare, P. Enzinger, T. Hong, 2012, Practical radiation oncology.

The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen

D. Livingston, E. Brown, H. Mamon, 1986, Molecular and cellular biology.

Thet-Unique Coding DomainIsImportant totheTransformation Maintenance Function oftheSimian Virus 40Small tAntigen

H. Mamon, M. Agha, 1986 .

Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer.

N. Choi, C. Fuchs, P. Enzinger, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

Ronald C. Chen, D. Ryan, T. Hong, 2012, International journal of radiation oncology, biology, physics.

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

D. Wigle, T. Dipetrillo, L. Kachnic, 2020 .

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.

A. Niemierko, C. Willett, B. Yeap, 2014, Practical radiation oncology.

Phase I/II study of Proton-based Short Course Chemoradiation and Early Surgery for Adenocarcinoma of the Pancreas

B. Yeap, D. Ryan, R. Wadlow, 2010 .

Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.

H. Mamon, R. Gobezie, T. Balboni, 2006, International journal of radiation oncology, biology, physics.

Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials

A. D'Amico, L. Trippa, J. Bellon, 2021, JAMA network open.

Differing effects of breast cancer 1, early onset (BRCA1) and ataxia‐telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation

J. Little, M. Muto, E. Azzam, 2003, International journal of radiation biology.

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

R. Berbeco, H. Mamon, M. Kulke, 2008, Nature Medicine.

Oncogenes, growth factors, and signal transduction.

T. Roberts, B. Druker, T. Roberts, 1989, The New England journal of medicine.

Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma

G. Getz, S. Carter, E. V. Van Allen, 2016, Clinical Cancer Research.

Enhanced detection of microsatellite instability using pre-PCR elimination of wild-type DNA homo-polymers in tissue and liquid biopsies

I. Ladas, H. Mamon, G. Makrigiorgos, 2018, Nucleic acids research.

Raf-1: A kinase currently without a cause but not lacking in effects

W. Haser, T. Roberts, H. Mamon, 1991, Cell.

A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

J. Tepper, R. Goldberg, D. Hollis, 2011, Cancer.

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Emily M. Thrash, A. Giobbie-Hurder, Helen X. Chen, 2021, Clinical Cancer Research.

Rectal and Colon Cancer: Background and Clinical Evidence

H. Mamon, S. Kamran, J. Wo, 2017 .

Optimal management of resectable gastric adenocarcinoma

H. Mamon, D. Buscariollo, 2015, Expert review of anticancer therapy.

Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer.

L. Kachnic, T. Hong, H. Mamon, 2013, Surgical oncology clinics of North America.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial

D. Wigle, T. Dipetrillo, L. Kachnic, 2022, The Lancet Oncology.

Is radiation therapy required for patients with intermediate-risk rectal cancer?

C. Willett, H. Mamon, 2007, Clinical advances in hematology & oncology : H&O.

Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.

B. Alexander, D. Ryan, T. Delaney, 2007, International journal of radiation oncology, biology, physics.

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

Jeffrey W. Clark, R. Jain, Y. Boucher, 2014, International journal of radiation oncology, biology, physics.

Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.

M. Mino‐Kenudson, B. Yeap, D. Ryan, 2011, International journal of radiation oncology, biology, physics.

Enhanced ratio of signals enables digital mutation scanning for rare allele detection.

C. Paweletz, P. Jänne, H. Mamon, 2015, The Journal of molecular diagnostics : JMD.

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.

M. Loda, E. Maher, S. Ogino, 2007, The Journal of molecular diagnostics : JMD.

Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment

H. Mamon, M. Kulke, Alexander Makrigiorgos, 2016, Nucleic acids research.

Differential strand separation at critical temperature: A minimally disruptive enrichment method for low-abundance unknown DNA mutations

H. Mamon, G. Makrigiorgos, Pingfang Liu, 2012, Nucleic acids research.

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer

T. Hong, H. Mamon, R. Nipp, 2017, Annals of Surgical Oncology.

Analysis of colorectal cancer patients treated on ETCTN 10021: A multicenter randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation.

A. Giobbie-Hurder, Helen X. Chen, F. Hodi, 2019, Journal of Clinical Oncology.

Adjuvant Treatment of Colorectal Cancer

J. Meyerhardt, B. Wolpin, R. Mayer, 2007, CA: a cancer journal for clinicians.

Interaction of the protein kinase Raf-1 with 14-3-3 proteins.

K. Xia, T. Roberts, D. Pallas, 1994, Science.

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Lipika Goyal, Christopher H Crane, Edgar Ben-Josef, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1

Simon C Watkins, R. Garcea, H. Mamon, 1991, Journal of virology.

Preferential amplification of apoptotic DNA from plasma: potential for enhancing detection of minor DNA alterations in circulating DNA.

C. Hader, H. Mamon, G. Makrigiorgos, 2008, Clinical chemistry.

Effect of Acetylcholine Receptor Source on Detection and Quantification of Anti – Acetylcholine Receptor – Binding Antibody

C. Hader, H. Mamon, K. Roper, 2008 .

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

J. Meyerhardt, C. Willett, C. Fuchs, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification

A. Shinagare, J. Jagannathan, B. Wolpin, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)

K. Owzar, M. Ratain, C. Willet, 2021, Pharmacogenetics and genomics.

Considerations in treatment planning for esophageal cancer.

T. Hong, H. Mamon, J. Killoran, 2007, Seminars in radiation oncology.

Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer

H. Mamon, Hwan Lee, Daniel W. Kim, 2019, Advances in radiation oncology.

Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.

A. Niemierko, N. Arvold, T. Hong, 2011, International journal of radiation oncology, biology, physics.

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.

P. Jänne, D. Sugarbaker, R. Bueno, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy.

C. Fuchs, S. Tirumani, H. Mamon, 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

Treatment planning for resected abdominal tumors: differences in organ position between diagnostic and radiation-planning computed tomography scans.

Aileen B Chen, H. Mamon, J. Killoran, 2005, International journal of radiation oncology, biology, physics.

Shielding of the hip prosthesis during radiation therapy for heterotopic ossification is associated with increased failure of prophylaxis.

H. Mamon, R. Gobezie, P. Gaccione, 2007, International journal of radiation oncology, biology, physics.

Multiplex amplification coupled with COLD-PCR and high resolution melting enables identification of low-abundance mutations in cancer samples with low DNA content.

S. Santagata, H. Mamon, G. Makrigiorgos, 2011, The Journal of molecular diagnostics : JMD.

An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer

J. Borrás, R. Tollenaar, E. Van Cutsem, 2017, JAMA oncology.

Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.

Daniel T Chang, Charles R. Thomas, Walter R Bosch, 2015, International journal of radiation oncology, biology, physics.

Quantifying Gadolinium-Based, Theranostic Nanoparticle Uptake in MR Images of Pancreatic Cancer

R. Mak, A. Sudhyadhom, J. Mancias, 2022, International Journal of Radiation Oncology*Biology*Physics.

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

T. Kolevska, L. Minasian, E. Basch, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.

A. Shinagare, J. Jagannathan, H. Mamon, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)

E. Basch, M. Weiser, L. Saltz, 2019, Clinical trials.

T3N0 rectal cancer: radiation for all?

D. Ryan, T. Hong, H. Mamon, 2011, Seminars in radiation oncology.

Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation

R. Blankstein, S. Dorbala, H. Mamon, 2020, Journal of Nuclear Cardiology.

Comparison of MR-soft tissue based versus biliary stent based alignment for image guidance in pancreatic SBRT.

R. Mak, A. Sudhyadhom, J. Mancias, 2023, Journal of applied clinical medical physics.

Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma.

C. Fuchs, H. Mamon, A. Nanda, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma

C. Fuchs, J. Tepper, R. Goldberg, 2005 .

NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR

I. Ladas, H. Mamon, V. Adalsteinsson, 2020, Nucleic acids research.

Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences

H. Hatabu, P. Enzinger, H. Mamon, 2020, European journal of radiology open.

FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer: Correlation With Histopathology Results

Harvey Mamon, Victor H. Gerbaudo, Marcelo Mamede, 2007, American journal of clinical oncology.

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy

Jeffrey W. Clark, D. Ryan, D. Ting, 2019, The oncologist.

High risk of brain metastases in surgically staged IIIA NSCLC patients treated with surgery, chemotherapy and radiation.

R. Bueno, B. Yeap, P. Janne, 2004, Journal of Clinical Oncology.

Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.

T. Kim, L. Dawson, W. Bosch, 2014, International Journal of Radiation Oncology, Biology, Physics.

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

J. Meyerhardt, L. Minasian, M. Weiser, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy for elderly patients with resected gastric adenocarcinoma

C. Earle, K. Hoffman, L. Kachnic, 2012, Cancer.

Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials

J. Ajani, G. Yothers, L. Kachnic, 2022, American journal of clinical oncology.

Playing With Dynamite? A Cautious Assessment of TNT.

H. Mamon, D. Shi, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ib study of neoadjuvant chemoradiation (CRT) with midostaurin, 5-fluorouracil (5-FU) and radiation (XRT) for locally advanced rectal cancer: Sensitization of RAS mutant tumors.

Jeffrey W. Clark, D. Rattner, A. Zhu, 2018 .

Automatic marker detection and 3D position reconstruction using cine EPID images for SBRT verification.

Ross Berbeco, Dan Ionascu, Sang-June Park, 2009, Medical physics.

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

R. Mak, N. Choi, C. Willett, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.

Marcelo Mamede, M. Mamede, T. Hong, 2008, International journal of radiation oncology, biology, physics.

Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response

P. Enzinger, J. Hornick, H. Mamon, 2018, Annals of Nuclear Medicine.

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

J. Meyerhardt, R. Bueno, N. Choi, 2016, BMC Cancer.

Development and validation of a pancreatic cancer prediction model from electronic health records using machine learning.

M. Rinard, I. Kaplan, J. Cambronero, 2020 .

A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.

P. Catalano, R. Bueno, P. Enzinger, 2017, Diseases of the esophagus.

Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma.

A. Ng, A. Recht, A. Freedman, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Preoperative Treatment of Locally Advanced Rectal Cancer.

J. Meyerhardt, K. Goodman, M. Weiser, 2023, The New England journal of medicine.

Florid Foreign Body-type Giant Cell Response to Keratin Is Associated With Improved Overall Survival in Patients Receiving Preoperative Therapy for Esophageal Squamous Cell Carcinoma

A. Bass, P. Enzinger, V. Deshpande, 2021, The American journal of surgical pathology.

Tyrosine phosphorylation in signal transduction.

T. Roberts, H. Piwnica-Worms, B. Schaffhausen, 1988, Cold Spring Harbor symposia on quantitative biology.

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).

J. Meyerhardt, K. Goodman, M. Weiser, 2023, Journal of Clinical Oncology.

Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer

A. Niemierko, M. Mino‐Kenudson, T. Hong, 2017, Pancreas.

Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.

A. Shinagare, M. Rosenthal, J. Jagannathan, 2017, Annals of Oncology.

to the letter to the editor ‘Borderline resectable pancreatic cancer: an evolving concept’

A. Shinagare, J. Jagannathan, H. Mamon, 2017 .

Improvements in beam’s eye view fiducial tracking using a novel multilayer imager

J. Seco, J. Mancias, R. Berbeco, 2021, Physics in medicine and biology.